In Reply: Beta-Blocker Use in Refractory Ascites
نویسندگان
چکیده
منابع مشابه
Beta-blocker under-use in COPD patients
BACKGROUND Cardiovascular (CVS) comorbidities are common in COPD and contribute significantly to morbidity and mortality, especially following acute exacerbations of COPD (AECOPD). Beta-blockers (BBs) are safe and effective in COPD patients, with demonstrated survival benefit following myocardial infarction. We sought to determine if BBs are under-prescribed in patients hospitalized with AECOPD...
متن کاملTesting the combination beta-blocker plus topiramate in refractory migraine.
OBJECTIVE To test treatment combining a beta-blocker plus topiramate in migraine patients previously resistant to the two medications in monotherapy. PATIENTS AND METHODS Those patients who had not responded to a beta-blocker and topiramate received combined treatment. RESULTS Fifty-eight patients (47 women, age 25-76 years) received the combined treatment. Thirty-three (57%) met criteria f...
متن کاملBeta-blocker use in decompensated heart failure.
Despite the current advances in treatment, acute decompensated heart failure accounts for more than 1 million hospital admissions annually. Many of the patients hospitalized are already receiving long-term treatment with beta-blockers. For patients who receive full dose beta-blocker therapy and suffer acute decompensated heart failure, clinicians face two key questions: what to do, if anything,...
متن کاملAscites, refractory ascites and hyponatremia in cirrhosis
Ascites is the most common complication related to cirrhosis and is associated with increased morbidity and mortality. Ascites is a consequence of the loss of compensatory mechanisms to maintain the overall effective arterial blood volume due to worsening splanchnic arterial vasodilation as a result of clinically significant portal hypertension. In order to maintain effective arterial blood vol...
متن کاملRefractory Chylous Ascites
A 34-year-old woman with primary chylous ascites due to lymphangiectasias was treated with sclerotherapy of dilated lymphatics and a lymphovenous shunt. She was referred to our institution after a thorough diagnostic and therapeutic approach in her community hospital. After four weeks of intensive diagnostic study, no secondary etiology for her chylous disorder was established. Conservative tre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Mayo Clinic Proceedings
سال: 2019
ISSN: 0025-6196
DOI: 10.1016/j.mayocp.2019.09.009